Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.05%
Monatliche Änderung
-12.03%
6 month change
-34.38%
Jahresänderung
-34.38%
Vorheriger Schlusskurs
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
Volumen
21
Märkte
Aktien
Gesundheitswesen
BNTC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
25.6 M
26.25 M
33.86 M
34.35 M
—
Valuation ratios
Enterprise value
229.46 M
209.43 M
380.59 M
273.95 M
1.09 B
Price to earnings ratio
-20.33
-11.14
-12.09
-12.36
-55.92
Price to sales ratio
—
507.36
-1 553.57
-1 491.56
—
Price to cash flow ratio
-7.79
-17.96
-19.05
-28.68
-73.48
Price to book ratio
0.55
4.35
1.29
1.17
7.36
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.09
0.06
0.33
Return on equity %
0.1
0.09
0.1
0.06
0.35
Return on invested capital %
—
—
—
—
—
Gross margin %
—
100
—
—
—
Operating margin %
—
-4 581.35
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-2 692.66
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.8
54.67
46.95
67.69
184.12
Inventory turnover
—
—
—
—
—
Asset turnover
0
-0
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.08
0.23
0.08
0.08
0.47
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
2.68
2.7
2.28
4.11
11.77
Net current asset value per share
2.69
2.72
2.29
4.12
11.83
Tangible book value per share
2.53
2.69
2.25
4.08
11.54
Working capital per share
2.51
2.67
2.24
4.06
11.49
Book value per share
2.53
2.69
2.25
4.08
11.54
Nachrichten
Gentherapie-Daten stützen Benitec-Aktie: Rating bestätigt
Benitec BioPharma stock rating maintained on gene therapy data
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Benitec BioPharma: Citizens bestätigt Einstufung "Market Outperform"
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma: TD Cowen bestätigt Kaufempfehlung nach starken OPMD-Studiendaten
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
Benitec BioPharma: Baird bestätigt "Outperform"-Rating und Kursziel von 30 US-Dollar
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
Benitec’s gene therapy shows durable results in OPMD patients
Monday’s Insider Moves: Dolphin CEO’s Big Bet Amid Notable Sells